Abstract:Key PointsSmall interfering RNAs (siRNAs) are widely used to study gene function and there is general excitement about their potential for therapeutic applications. However, several hurdles, including a lack of specificity, will have to be overcome before it is possible to use siRNAs therapeutically.siRNAs have multiple types of off-target effects, but there are several methods to help mitigate them.microRNA-like off-target effects refer to siRNA-induced sequence-dependent regulation of unintended transcripts, through partial sequence complementarity to their 3′ UTRs, to produce false-positive phenotypes. Such off-target effects follow the same dose response as on-target effects and therefore cannot be selectively eliminated by reducing siRNA concentration. Off-target siRNA effects are also species-specific.microRNA-like off-target effects can be mitigated by siRNA redundancy, siRNA pooling or chemical modification such as 2′-O-methyl modification.A significant obstacle to the therapeutic application of RNAi is the ability of siRNAs and/or their delivery vehicles (such as cationic lipids) to stimulate the innate immune system and trigger an inflammatory response through activation of Toll-like receptors. Immunostimulatory siRNAs can also produce unwanted toxicities, including elevated levels of serum alanine and aspartate aminotransaminases, and reduced numbers of lymphocytes and platelets.Immunostimulation by siRNAs can be reduced by sequence selection or chemical modification such as substitution of the 2′ position of ribose with 2′-O-methyl, 2′-fluoro, 2′-deoxy or locked nucleic acid.A novel non-specific effect of RNAi expression relates to saturation of the RNAi machinery; exogenous siRNAs can saturate the endogenous RNAi machinery causing widespread effects on microRNA processing and function.Understanding the sources of siRNA off-target activity is yielding insights into siRNA design and chemical modification. Much progress has been made in the design of effective siRNAs with reduced off-target liabilities and continued research in this area will undoubtedly lead to further improvements in the development of siRNAs for therapeutic applications.

Expression profiling reveals off-target gene regulation by RNAi

Application of short hairpin RNAs (shRNAs) to study gene function in mammalian systems

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

siRNAs can function as miRNAs

A Systematic Analysis of the Silencing Effects of an Active Sirna at All Single-Nucleotide Mismatched Target Sites

Off-target effects of RNAi correlate with the mismatch rate between dsRNA and non-target mRNA

An Efficient RNA Interference Screening Strategy for Gene Functional Analysis

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application

SY-9 Stimulation of Innate Immunity by Short Interfering and Micro RNAs

siRNA Design Software for a Target Gene-Specific RNA Interference

Discovery of a Dicer-Independent, Cell-Type Dependent Alternate Targeting Sequence Generator: Implications in Gene Silencing & Pooled RNAi Screens

Analysis of Sirna Specificity on Targets with Double-Nucleotide Mismatches.

siRNA Specificity: RNAi Mechanisms and Strategies to Reduce Off-Target Effects

Modulation of Gene Expression by Lentiviral-Mediated Delivery of Small Interfering RNA

Nuclear RNAi Contributes to the Silencing of Off-Target Genes and Repetitive Sequences in Caenorhabditis Elegans

Interactions between the non-seed region of siRNA and RNA-binding RLC/RISC proteins, Ago and TRBP, in mammalian cells

Application of RNA Interference in Mammalian Cells

Regulation and Imaging of Gene Expression Via an RNA Interference Antagonistic Biomimetic Probe

RNA-Induced Silencing Complex-Bound Small Interfering RNA Is a Determinant of RNA Interference-Mediated Gene Silencing in Mice

Profiling of Mismatch Discrimination in RNAi Enabled Rational Design of Allele-Specific Sirnas

[RNA Interference in Functional Genomics and Medical Research].